Event Details

Oral Presentation:
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg <100 IU/mL threshold

• Presentation Reference: PS-080
• Session: Parallel session: Hepatitis B - drug development
• Date and Time: April 12, 2019 at 5:45 p.m. CET
• Authors: Man-Fung Yuen, et al.

Poster Presentation:
Reduction of hepatic Z-alpha1 antitrypsin by RNA interference (RNAi) prevents and reverses liver disease including hepatic mitochondrial injury in the PiZ mouse model

• Presentation Reference: FRI-446
• Session: Poster: Rare liver diseases (including pediatric and genetic)
• Session Date and Time: April 12, 2019 from 9 a.m. to 5 p.m. CET
• Authors: Christine Wooddell, et al.